Felisecto Plus


selamectin / sarolaner

This medicine is authorised for use in the European Union.


Felisecto Plus is a medicine used to treat mixed infestations with both ticks and other parasites that may be found on the skin or fur of cats, such as fleas, ear mites and lice and/or worms that can enter and infect the body. The medicine can be used:

  • to treat tick infestations

  • to treat and prevent flea infestations. It can also be used as part of a treatment for flea allergy dermatitis (an allergic reaction to flea bites)

  • to treat ear mites

  • to treat biting lice infestations

  • to treat adult roundworms and adult hookworms in the gut

  • to prevent heartworm disease

Felisecto Plus must only be used when there is a need to treat ticks and one or more of the above parasites. Felisecto Plus contains two active substances, selamectin and sarolaner.

For more information, see the package leaflet.

This medicine is the same as Stronghold Plus, which is already authorised in the European Union (EU). The company that makes Stronghold Plus has agreed that its scientific data can be used for Felisecto Plus (‘informed consent’).

This EPAR was last updated on 15/06/2021

Authorisation details

Product details
Felisecto Plus
Agency product number
Active substance
  • selamectin
  • sarolaner
International non-proprietary name (INN) or common name
  • selamectin
  • sarolaner
Anatomical therapeutic chemical veterinary (ATCvet) codes
Publication details
Marketing-authorisation holder
Zoetis Belgium SA
Date of issue of marketing authorisation valid throughout the European Union
Contact address

Rue Laid Burniat 1
1348 Louvain-la-Neuve

Product information

11/06/2021 Felisecto Plus - EMEA/V/C/005093 - IB/0004

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.


Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Antiparasitic products, insecticides and repellents

Therapeutic indication

For cats with, or at risk from, mixed parasitic infestations by ticks and fleas, lice, mites, gastrointestinal nematodes or heartworm. The veterinary medicinal product is exclusively indicated when use against ticks and one or more of the other target parasites is indicated at the same time.

Assessment history

How useful was this page?

Add your rating
2 ratings
1 rating
1 rating